Sanjana NEMADE, Pratibha SAMPATE, Kiran SHINDE

Clinical efficacy of combined treatment with trichloroacetic acid chemical cautery and steroid spray in allergic rhinitis with inferior turbinate hypertrophy

Objectives: Comparison between efficacy of combined treatment with trichloroacetic acid (TCA) chemical cautery and steroid nasalspray in the treatment of allergic rhinitis (AR) with inferior turbinate hypertrophy (ITH).Patients and Methods: A total of 132 patients with ITH due to AR were included in the study. Forty-four patients each were treatedwith TCA chemical cauterization of inferior turbinate (Group A), steroid nasal spray (Group B), or combined treatment with TCAcautery and steroid nasal spray (Group C). The Symptom Severity Grade (SSG) 1-5 based on a validated Questionnaire Sheet (QS)as well as Visual Analog Scale were documented before and after treatment.Results: Before treatment, the SSG was 3-5 in 37 (84%), 36 (81.8%), and 40 (90.9%) patients in groups A, B, and C, respectively. Atsix months post-treatment, SSG 1-2 was achieved in 20 patients (45.4%) in Group A, 18 patients (40.9%) in group B and 31 patients(70.4%) in Group C. Statistically significant improvement was found in patients who received the combined treatment.Conclusion: Combined treatment with TCA chemical cauterization of inferior turbinate and steroid nasal spray can be effectivetherapy for amelioration of symptoms of AR and ITH.

PDF

___

1. Harrow B, Sedaghat AR, Caldwell-Tarr A, Dufour R. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on SingleProduct or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines. J Manag Care Spec Pharm 2016;22:1426-36.
2. Aslam MJ, Aslam MA, Khan AS, Hussain A, Sharif A. Treatment of nasal obstruction due to hypertrophic inferior turbinates with application of silver nitrate solution. Ann Pak Inst Med Sci 2009;5:201-5.
3. Fernandes de Azevedo A, Martins DA, Cardoso CG, Candido de Moraes I, Pereira Michel LM, Rios Leite LH. Chemical cautery of the inferior turbinates with trichloroacetic acid. Int Arch Otorhinolaryngol 2011;15:475-7.
4. Badorrek P, Hohlfeld JM, Krug N, Joshi A, Raut A. Efficacy and safety of a novel nasal steroid, S0597, in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2015;115:325-9.e1.
5. Sözen E, Tansuker D, Yldrm Ö, Uçal YO, Coşkun BU. Effects of radiofrequency and intranasal steroid treatments on respiratory and olfactory functions in nasal obstruction. J Craniofac Surg 2013;24:e314-8.
6. Al-Anbaki F, Al-Sarhan H. Evaluation of treatment of sneezing and rhinorrhoea by local application of Trichloroacetic acid in patients with non infective rhinitis. Iraqi J Comm Med 2009;22:192-6.
7. Yao K, Sato K, Usui D, Kurihara R, Okamoto M, Iguchi Y, et al. Chemosurgery with trichloroacetic acid for allergic rhinitis: evaluation of the efficacy in terms of inhibition of Th2 cell infiltration. Auris Nasus Larynx 2009;36:292-9.
8. Bayram AA, Bayram Ö, Balıkcı HH, Özkül MH, Chatzi T, Karakas M et al. Long-term effects of fluticasone furoate assessed using peak nasal inspiratory flow in patients with non-allergic inferior turbinate hypertrophy. BAOJ Aller Immunol 2017;3:011.